A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors
Clinical trial NCT02590952 · COMPLETED
Trial details
- NCT number
- NCT02590952
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-31
- Primary completion
- 2019-04-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.